Deutsch English Français

Contact

EP2667869

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2667869

EP2667869 - USE OF POTASSIUM CHANNEL BLOCKERS TO TREAT CEREBRAL PALSY [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 20.11.2015 Database last updated on 29.06.2024
Most recent event Tooltip	20.11.2015	Application deemed to be withdrawn	published on 23.12.2015 [2015/52]
Applicant(s)	For all designated states Acorda Therapeutics, Inc. 15 Skyline Drive Hawthorne, NY 10532 / US
	[2013/49]
Inventor(s)	01 / WESSEL, Thomas, C. 22 Cliffwood Street Lenox, MA 12040 / US
	02 / RABINOWICZ, Adrian, L. 6 Vultee Drive Florham Park, NJ 07932 / US
	03 / HENNEY III, Herbert, R. 322 Fox Chase Road Clarksboro, NJ 08020 / US
	04 / RUNYAN, Jacob, D. 13 McNulty Drive New Milford, CT 06776 / US
	05 / CAGGIANO, Anthony 10 Wildwood Road Larchmont, NY 10538 / US
	06 / BLIGHT, Andrew 10 Oskar Drive Mahopac, NY 10541 / US
	[2013/49]
Representative(s)	Warner, James Alexander Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[2013/49]
Application number, filing date	12702948.6	27.01.2012
	WO2012US22960
Priority number, date	US201161437558P	28.01.2011 Original published format: US 201161437558 P
	[2013/49]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2012103471
	Date:	02.08.2012
	Language:	EN
	[2012/31]
	Type:	A1 Application with search report
	No.:	EP2667869
	Date:	04.12.2013
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.08.2012 takes the place of the publication of the European patent application.
	[2013/49]
Search report(s)	International search report - published on:	EP	02.08.2012
Classification	IPC:	A61K31/44, A61P25/14	[2013/49]
	CPC:	A61K31/44 (EP,US); A61K31/4409 (EP,US); A61P21/00 (EP); A61P25/00 (EP); A61P25/02 (EP); A61P25/14 (EP)
	C-Set:	A61K2300/00, A61K31/44 (US); A61K2300/00, A61K31/4409 (US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/49]
Title	German:	VERWENDUNG VON KALIUMKANALBLOCKERN ZUR BEHANDLUNG VON ZEREBRALPARESE	[2013/49]
	English:	USE OF POTASSIUM CHANNEL BLOCKERS TO TREAT CEREBRAL PALSY	[2013/49]
	French:	UTILISATION D'INHIBITEURS DES CANAUX POTASSIQUES DANS LE TRAITEMENT D'UNE PARALYSIE CÉRÉBRALE	[2013/49]
Entry into regional phase	28.08.2013	National basic fee paid
	28.08.2013	Designation fee(s) paid
	28.08.2013	Examination fee paid
Examination procedure	28.08.2013	Examination requested [2013/49]
	25.04.2014	Despatch of communication of loss of particular rights: Claims {1}
	07.07.2014	Amendment by applicant (claims and/or description)
	29.09.2014	Despatch of a communication from the examining division (Time limit: M02)
	09.12.2014	Reply to a communication from the examining division
	10.02.2015	Communication of intention to grant the patent
	23.06.2015	Application deemed to be withdrawn, date of legal effect [2015/52]
	31.07.2015	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2015/52]
Divisional application(s)	EP15172998.5 / EP2995305
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.09.2014
Request for further processing for:	07.07.2014	Request for further processing filed
	07.07.2014	Full payment received (date of receipt of payment) Request granted
	18.07.2014	Decision despatched
Fees paid	Renewal fee
	27.01.2014	Renewal fee patent year 03
	27.01.2015	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XP]WO2011019845 (ACORDA THERAPEUTICS INC [US], et al) [XP] 1-17,39-42,46 * page 25, line 14; claims 1,2 *;
		[I]WO2010093838 (ACORDA THERAPEUTICS INC [US], et al) [I] 1-47 * paragraphs [0272] , [ 343] , [0344]; example 2; table 15 *;
		[I]WO2005099701 (ACORDA THERAPEUTICS INC [US], et al) [I] 1-47 * paragraph [0041]; example 5 *;
		[I]WO9414439 (CANADIAN SPINAL RES ORG [CA], et al) [I] 1-47 * page 17, lines 10-25; claim 5 *;
		[A]WO2008036294 (UNIV NORTHWESTERN [US], et al) [A] 1-47 * claims 1,6,12 *;
		[A] - JI HAITAO ET AL, "Prevention of cerebral palsy with de novo designed neuronal nitric oxide synthase selective inhibitors", NITRIC OXIDE, 5TH INTERNATIONAL CONFERENCE ON BIOLOGY, CHEMISTRY, AND THERAPEUTIC APPLICATIONS OF NITRIC OXIDE; BREGENZ, AUSTRIA; AUGUST 24 -28, 2008, (2008), vol. 19, no. Suppl. S, doi:10.1016/J.NIOX.2008.06.070, ISSN 1089-8603, page S36, XP002670416 [A] 1-47 * abstract * DOI: http://dx.doi.org/10.1016/J.NIOX.2008.06.070
		[A] - HAWAMDEH Z M ET AL, "Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy", EUROPA MEDICOPHYSICA, MINERVA MEDICA, TORINO, IT, (20070901), vol. 43, no. 3, ISSN 0014-2573, pages 311 - 318, XP009156868 [A] 1-47 * the whole document *
	Examination	- JOHNSTON MICHAEL V ET AL, "Models of cerebral palsy: which ones are best?", JOURNAL OF CHILD NEUROLOGY DEC 2005, (200512), vol. 20, no. 12, ISSN 0883-0738, pages 984 - 987, XP009180313 DOI: http://dx.doi.org/10.1177/08830738050200121001
	by applicant	US5952357
		US2005276851
		US2005228030
		- LIN, J NEUROL NEUROSURG PSYCHIATRY, (2003), vol. 74, pages I23 - I29
		- BEUKELMAN; MIRENDA, Augmentative and Alternative Communication: Management of severe communication disorders in children and adults, BALTIMORE: PAUL H BROOKES PUBLISHING CO., (1999), pages 246 - 249
		- CEREBRAL PALSY - TOPIC OVERVIEW
		- CARLSSON ET AL., DEV MED CHILD NEUROL, (2003), vol. 45, pages 371 - 376
		- HUMPHREYS ET AL., J CHILD NEUROL, (2007), vol. 22, pages 598 - 605
		- ZELNIK ET AL., EUR J PAEDIATR NEUROL, (2010), vol. 14, pages 67 - 72
		- KRIGGER ET AL., AM FAM PHYSICIAN, (2006), vol. 73, pages 91 - 100
		- KOMAN ET AL., LANCET, (2004), vol. 363, pages 1619 - 1631
		- JOHNSTON ET AL., NEUROMOLECULAR MED, (2006), vol. 8, pages 435 - 450
		- MMWR MORB MORTAL WKLY REP, (2004), vol. 53, pages 57 - 59
		- ODDING ET AL., DISABIL REHABIL, (2006), vol. 28, pages 183 - 191
		- INFORMATION: SCOPE
		- Medical News: Cerebral Palsy Rates Decline in Very Low Birthweight Children, NEUROLOGY, GENERAL NEUROLOGY
		- BAX ET AL., JAMA, (2006), vol. 296, pages 1602 - 1608
		- FOLKERTH ET AL., J CHILD NEUROL, (2005), vol. 20, pages 940 - 949
		- DERRICK ET AL., STROKE, (2007), vol. 38, pages 731 - 735
		- VOLPE ET AL., PEDIATRIC RES, (2001), vol. 50, pages 553 - 562
		- BACK ET AL., STROKE, (2007), vol. 38, pages 724 - 730
		- DENG ET AL., ARCH NEUROL, (2008), vol. 65, pages 1291 - 1295
		- BEAINO ET AL., DEV MED CHILD NEUROL, (2010), vol. 52, pages E119 - EL25
		- THOMAS ET AL., BRAIN, (2005), vol. 128, pages 2562 - 2577
		- HOON ET AL., DEV MED CHILD NEUROL, (2009), vol. 51, pages 697 - 704
		- BECKUNG ET AL., PEDIATRICS, (2008), vol. 121, pages E187 - E192
		- WU ET AL., PEDIATRICS, (2006), vol. 118, pages 690 - 697
		- JOHNSON ET AL., DEV MED CHILD NEUROL, (2002), vol. 44, pages 633 - 640
		- MIKKOLA ET AL., PEDIATRICS, (2005), vol. 116, pages 1391 - 1400
		- ROBERTSON ET AL., JAMA, (2007), vol. 297, pages 2733 - 2740
		- BEAINO ET AL., DEV MED CHILD NEUROL, (2010), vol. 52, pages E119 - E125
		- O'SHEA ET AL., PEDIATRICS, (1998), vol. 101, pages 642 - 647
		- STRAUSS ET AL., DEV MED CHILD NEUROL, (1998), vol. 40, pages 369 - 375
		- HEMMING ET AL., DEV MED CHILD NEUROL, (2006), vol. 48, pages 90 - 95
		- RAPP CE ET AL., ARCH FAM MED., (2000), vol. 9, pages 466 - 472
		- HIRTZ ET AL., NEUROLOGY, (2007), vol. 68, pages 326 - 337
		- JENKS ET AL., DEV NEUROPSYCHOL, (2007), vol. 32, pages 861 - 879
		- STRAUSS ET AL., DEV MED CHILD NEUROL, (2008), vol. 50, pages 487 - 493
		- STRAUSS ET AL., NEUROREHABILITATION, (2004), vol. 19, pages 69 - 78
		- MCKEAMAN ET AL., J NEUROSCI NURS, (2004), vol. 26, pages 252 - 259
		- NEWMAN ET AL., DEV MED CHILD NEUROL, (2006), vol. 48, pages 564 - 568
		- HAWAMDEH ET AL., EUROPA MEDICOPHYSICA, (2007), vol. 43, pages 311 - 318
		- SCHEJBALOVA ET AL., ACTA CHIR ORTHOP TRAUMATOL CECH, (2006), vol. 73, pages 334 - 339
		- WHITE ET AL., DEV MED CHILD NEUROL, (2002), vol. 44, pages 227 - 232
		- GOODMAN ET AL., LANCET, (2009), vol. 373, pages 732 - 738
		- GOODMAN ET AL., ANN NEUROL, (2010), vol. 68, pages 494 - 502
		- GOODMAN ET AL., NEUROLOGY, (2008), vol. 71, pages 1134 - 1141
		- GOODMAN ET AL., ANN NEUROL, (2010), vol. 373, pages 494 - 502
		- S.M. BARGE ET AL., "Pharmaceutical Salts", J. PHARM. SCI., (1977), vol. 66, pages 1 - 19
		- DERRICK ET AL., STROKE, (2007), vol. 38, no. 2, pages 731 - 735
		- STOLP ET AL., NEUROPATHOL APPL NEUROBIOL., (2009), vol. 35, pages 132 - 146
		- FISCHER J ET AL., The Multiple Sclerosis Functional Composite Administration and Scoring Manual, NATIONAL MULTIPLE SCLEROSIS SOCIETY, (2001), pages 1 - 41
		- BOHANNON, AGE AGEING, (1997), vol. 26, pages 15 - 19
		- MATHIOWETZ ET AL., AM J OCCUP THER, (1985), vol. 36, pages 386 - 391
		- MATHIOWETZ ET AL., ARCH PHYS MED REHABIL, (1985), vol. 66, pages 69 - 72
		- LIN JP, "The cerebral palsies: a physiological approach", J NEUROL NEUROSURG PSYCHIATRY, (2003), vol. 74, no. 1, pages I23 - I29
		- KRIGGER KW, "Cerebral palsy: an overview", AM FAM PHYSICIAN., (2006), vol. 73, no. 1, pages 91 - 100
		- ODDING E; ROEBROECK ME; STAM HJ., "The epidemiology of cerebral palsy: incidence, impairments and risk factors", DISABIL REHABIL., (2006), vol. 28, no. 4, pages 183 - 191
		- KOMAN LA; SMITH BP; SHILT JS, "Cerebral palsy", LANCET, (2004), vol. 363, no. 9421, pages 1619 - 1631
		- CARLSSON M; HAGBERG G; OLSSON I, "Clinical and aetiological aspects of epilepsy in children with cerebral palsy", DEV MED CHILD NEUROL., (2003), vol. 45, no. 6, pages 371 - 376
		- HUMPHREYS P; DEONANDAN R; WHITING S ET AL., "Factors associated with epilepsy in children with periventricular leukomalacia", J CHILD NEUROL., (2007), vol. 22, no. 5, pages 598 - 605
		- ZELNIK N; KONOPNICKI M; BENNETT-BACK O; CASTEL-DEUTSCH T; TIROSH E., "Risk factors for epilepsy in children with cerebral palsy", EUR J PAEDIATR NEUROL., (2010), vol. 14, no. 1, pages 67 - 72
		- JOHNSTON MV; HOON AH JR., "Cerebral palsy", NEUROMOLECULAR MED., (2006), vol. 8, no. 4, pages 435 - 450
		- BAX M; TYDEMAN C; FLODMARK O, "Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study", JAMA, (2006), vol. 296, no. 13, pages 1602 - 1608
	- FOLKERTH RD, "Neuropathologic substrate of cerebral palsy", J. CHILD NEUROL., (2005), vol. 20, no. 12, pages 940 - 949
	- WU YW; CROEN LA; SHAH SJ; NEWMAN TB; NAJJAR DV., "Cerebral palsy in a term population: risk factors and neuroimaging findings", PEDIATRICS, (2006), vol. 118, no. 2, pages 690 - 697
	- PEDIATRICS, (2005), vol. 116, no. 6, pages 1391 - 1400
	- ROBERTSON CM; WATT MJ; YASUI Y, "Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years", JAMA, (2007), vol. 297, no. 24, pages 2733 - 2740
	- BEAINO G; KHOSHNOOD B; KAMINSKI M ET AL., "Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study", DEV MED CHILD NEUROL., (2010), vol. 52, no. 6, pages E119 - E125
	- O'SHEA TM; PREISSER JS; KLINEPETER KL; DILLARD RG, "Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994", PEDIATRICS, (1998), vol. 101, pages 642 - 647
	- STRAUSS D; SHAVELLE R., "Life expectancy of adults with cerebral palsy", DEV MED CHILD NEUROL., (1998), vol. 40, no. 6, pages 369 - 375
	- HEMMING K; HUTTON JL; PHAROAH PO., "Long-term survival for a cohort of adults with cerebral palsy", DEV MED CHILD NEUROL., (2006), vol. 48, no. 2, pages 90 - 95
	- RAPP CE; TORRES M., "The adult with cerebral palsy", ARCH FAM MED., (2000), vol. 9, pages 466 - 472
	- VOLPE JJ., "Neurobiology of periventricular leukomalacia in the premature infant", PEDIATRIC RES., (2001), vol. 50, no. 5, pages 553 - 562
	- BACK SA; RIDDLE A; MCCLURE MM., "Maturation-dependent vulnerability of perinatal white matter in premature birth", STROKE, (2007), vol. 38, no. 2, pages 724 - 730
	- DENG W; PLEASURE J; PLEASURE D., "Progress in periventricular leukomalacia", ARCH NEUROL., (2008), vol. 65, no. 10, pages 1291 - 1295
	- THOMAS B; EYSSEN M; PEETERS R ET AL., "Quantitative diffusion tensor imaging in cerebral palsy due to periventricular white matter injury", BRAIN, (2005), vol. 128, pages 2562 - 2577
	- HOON AH JR; STASHINKO EE; NAGAE LM ET AL., "Sensory and motor deficits in children with cerebral palsy born preterm correlate with diffusion tensor imaging abnormalities in thalamocortical pathways", DEV MED CHILD NEUROL., (2009), vol. 51, no. 9, pages 697 - 704
	- BECKUNG E; HAGBERG G; ULDALL P; CANS C., "Surveillance of Cerebral Palsy in Europe. Probability of walking in children with cerebral palsy in Europe", PEDIATRICS, (2008), vol. 121, no. 1, pages E187 - E192
	- STRAUSS D; OJDANA K; SHAVELLE R; ROSENBLOOM L., "Decline in function and life expectancy of older persons with cerebral palsy", NEUROREHABILITATION, (2004), vol. 19, no. 1, pages 69 - 78
	- GOODMAN AD; BROWN TR; COHEN JA ET AL., "Dose comparison trial of sustained-release fampridine in multiple sclerosis", NEUROLOGY, (2008), vol. 71, pages 1134 - 1141
	- GOODMAN AD; BROWN TR; KRUPP LB, "Sustained-release oral fampridine in multiple sclerosis: a randomized, double-blind, controlled trial", LANCET, (2009), vol. 373, pages 732 - 738
	- GOODMAN AD; BROWN TR; EDWARDS KR ET AL., "A Phase 3 trial of extended release oral dalfampridine in multiple sclerosis", ANN NEUROL., (2010), vol. 373, doi:doi:10.1002/ana.22240, pages 494 - 502, XP055088768 DOI: http://dx.doi.org/10.1002/ana.22240
	- NEUROPATHOL APPL NEUROBIOL., (2009), vol. 35, pages 132 - 146
	- AKSU F., "Nature and prognosis of seizures in patients with cerebral palsy", DEV MED CLIN NEUROL., (1990), vol. 32, pages 661 - 668
	- MCDERMOTT S; MORAN R; PLATT T ET AL., "Prevalence of epilepsy in adults with mental retardation and related disabilities in primary care", AM J MENT RETARD., (2005), vol. 110, pages 48 - 56
	- ASHWAL S; RUSSMAN RS; BLASCO PA ET AL., "Practice parameter: Diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society", NEUROLOGY, (2004), vol. 62, no. 6, pages 851 - 63
	- FISCHER J ET AL., "The Multiple Sclerosis Functional Composite Administration and Scoring Manual", NATIONAL MULTIPLE SCLEROSIS SOCIETY, (2001), pages 1 - 41
	- BOHANNON R, "Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants", AGE AND AGEING., (1997), vol. 26, pages 15 - 19
	- MATHIOWETZ V; VOLLAND G; KASHMAN N ET AL., "Adult norms for the Box and Block Test of manual dexterity", AM J OCCUP THER., (1985), vol. 36, no. 6, pages 386 - 391
	- MATHIOWETZ V; KASHMAN N; VOLLAND G ET AL., "Grip and pinch strength; normative data for adults", ARCH PHYS MED REHABIL., (1985), vol. 66, pages 69 - 72
	- FISCHER J ET AL., NATIONAL MULTIPLE SCLEROSIS SOCIETY, (2001), pages 1 - 41
	- BOHANNON R., AGE AND AGEING, (1997), vol. 26, pages 15 - 19
	- MATHIOWETZ V; VOLLAND G; KASHMAN N ET AL., AM J OCCUP THER., (1985), vol. 36, no. 6, pages 386 - 391
	- MATHIOWETZ V; KASHMAN N; VOLLAND G ET AL., ARCH PHYS MED REHABIL., (1985), vol. 66, pages 69 - 72
	- LIN JP., "The cerebral palsies: a physiological approach", JNEUROL NEUROSURG PSYCHIATRY, (2003), vol. 74, no. 1, pages I23 - I29
	- CARLSSON M; HAGBERG G; OLSSON I., "Clinical and aetiological aspects of epilepsy in children with cerebral palsy", DEV MED CHILD NEUROL., (2003), vol. 45, no. 6, pages 371 - 376
	- ZELNIK N; KONOPNICKI M; BENNETT-BACK 0; CASTEL-DEUTSCH T; TIROSH E, "Risk factors for epilepsy in children with cerebral palsy", EURJ PAEDIATR NEUROL., (2010), vol. 14, no. 1, pages 67 - 72
	- JOHNSTON MV; HOON AH JR; CEREBRAL PALSY, NEUROMOLECULAR MED., (2006), vol. 8, no. 4, pages 435 - 450
	- BAX M; TYDEMAN C; FLODMARK O., "Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study", JAMA, (2006), vol. 296, no. 13, pages 1602 - 1608
	- FOLKERTH RD., "Neuropathologic substrate of cerebral palsy", J. CHILD NEUROL., (2005), vol. 20, no. 12, pages 940 - 949
	- WU YW; CROEN LA; SHAH SJ; NEWMAN TB; NAJJAR DV, "Cerebral palsy in a term population: risk factors and neuroimaging findings", PEDIATRICS, (2006), vol. 118, no. 2, pages 690 - 697
	- CEREBRAL PALSY: HOPE THROUGH RESEARCH: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, (20110420), URL: http://www.ninds.nih.gov/disorders/cerebral_palsy/detail_cerebral_palsy.htm#154443104
	- BECKUNG E; HAGBERG G; ULDALL P; CANS C, "Surveillance of Cerebral Palsy in Europe. Probability of walking in children with cerebral palsy in Europe", PEDIATRICS, (2008), vol. 121, no. 1, pages E187 - E192
	- GOODMAN AD; BROWN TR; KRUPP LB ET AL., "Sustained-release oral fampridine in multiple sclerosis: a randomized, double-blind, controlled trial", LANCET, (2009), vol. 373, pages 732 - 738
	- AKSU F, "Nature and prognosis of seizures in patients with cerebral palsy", DEV MED CLIN NEUROL., (1990), vol. 32, pages 661 - 668
	- MATHIOWETZ V; VOLLAND G; KASHMAN N ET AL., "Adult norms for the Box and Block Test of manual dexterity", AM J OCCUP THER., (1985), vol. 36, pages 386 - 391

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p